Status:
COMPLETED
Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Ovarian Cancer
Fallopian Tube
Eligibility:
FEMALE
19+ years
Phase:
NA
Brief Summary
The purpose of this study is to see if Positron Emission Tomography (PET) probes make it easier for your surgeon to find cancer and remove it during your surgery. A PET probe is a wandlike device that...
Eligibility Criteria
Inclusion
- Pathologically proven diagnosis of ovarian carcinoma, fallopian tube, or primary peritoneal not to include tumors of low malignant potential (all stage, grade, and histology)
- First recurrence
- Platinum sensitive as defined by disease free interval ≥ 6 months
- Radiological evidence of recurrent disease on preoperative PET/diagnostic CT
- Planned surgical secondary cytoreduction via laparotomy
- \>18 years old
Exclusion
- Secondary cytoreduction via laparoscopy or robotically assisted laparoscopy
- Tumors of low malignant potential
- Beyond first recurrence
- With the exception of non-melanoma skin cancer, subjects with other invasive malignancies, who had (or have) any evidence of the other cancer present within the last 5 years, are excluded
- Active infection requiring parenteral antibiotics
- For subjects with diabetes mellitus, a blood sugar will be checked preoperatively and must be \<200 for participation in the study
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT01826227
Start Date
March 1 2013
End Date
December 1 2016
Last Update
November 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065